Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,884 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stop-flow in mediastinum and thorax for resistant lymphoma.
Guadagni S, Russo F, Abate G, Pozone T, Capannolo B, Marsili L, D'Alessandro V, Amicucci G, Aigner KR. Guadagni S, et al. Among authors: russo f. Hepatogastroenterology. 2000 Mar-Apr;47(32):378-82. Hepatogastroenterology. 2000. PMID: 10791194 Clinical Trial.
Chronic lymphocytic leukaemia and neuroendocrine cancer.
Russo F, Guadagni S, Corazzelli G, Frigeri F, Monda VM, Abate G. Russo F, et al. Br J Haematol. 1999 Jun;105(4):989-92. doi: 10.1046/j.1365-2141.1999.01472.x. Br J Haematol. 1999. PMID: 10554811 Free article.
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.
Russo F, Corazzelli G, Frigeri F, Capobianco G, Aloj L, Volzone F, De Chiara A, Bonelli A, Gatani T, Marcacci G, Donnarumma D, Becchimanzi C, de Lutio E, Ionna F, De Filippi R, Lastoria S, Pinto A. Russo F, et al. Br J Haematol. 2014 Jul;166(1):118-29. doi: 10.1111/bjh.12862. Epub 2014 Mar 27. Br J Haematol. 2014. PMID: 24673727 Free article. Clinical Trial.
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.
Corazzelli G, Capobianco G, Arcamone M, Ballerini PF, Iannitto E, Russo F, Frigeri F, Becchimanzi C, Marcacci G, De Chiara A, Pinto A. Corazzelli G, et al. Among authors: russo f. Cancer Chemother Pharmacol. 2009 Oct;64(5):907-16. doi: 10.1007/s00280-009-0941-9. Epub 2009 Feb 15. Cancer Chemother Pharmacol. 2009. PMID: 19219604
1,884 results